Rituximab Improves Rate and Duration of Chemotherapy-Induced Remissions in Indolent and Aggressive Non-Hodgkin's Lymphoma.

Abstract

Sorry, we couldn't extract an abstract for this paper.

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.